AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI)

CUSIP: 00901B105

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
67,129,058
Total 13F shares
7,420,355
Share change
+4,301,609
Total reported value
$16,843,868
Price per share
$2.27
Number of holders
32
Value change
+$9,793,564
Number of buys
21
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 00901B105?
CUSIP 00901B105 identifies AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
MORGAN STANLEY
13F
Company
1.5%
998,815
$1,788,000 31 Dec 2020
13F
VANGUARD GROUP INC
13F
Company
0.85%
572,131
$1,025,000 31 Dec 2020
13F
BlackRock Finance, Inc.
13F
Company
0.76%
510,796
$914,000 31 Dec 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.35%
234,991
$420,000 31 Dec 2020
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.17%
116,800
$209,000 31 Dec 2020
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.17%
111,000
$199,000 31 Dec 2020
13F
Virtu Financial LLC
13F
Company
0.15%
103,807
$186,000 31 Dec 2020
13F
NORTHERN TRUST CORP
13F
Company
0.1%
64,303
$115,000 31 Dec 2020
13F
Verition Fund Management LLC
13F
Company
0.09%
60,000
$107,000 31 Dec 2020
13F
SeaCrest Wealth Management, LLC
13F
Company
0.07%
48,873
$87,000 31 Dec 2020
13F
Cambridge Investment Research Advisors, Inc.
13F
Company
0.06%
40,679
$73,000 31 Dec 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.06%
40,560
$73,000 31 Dec 2020
13F
Bank of New York Mellon Corp
13F
Company
0.04%
28,003
$50,000 31 Dec 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.03%
20,316
$37,000 31 Dec 2020
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.03%
20,200
$36,000 31 Dec 2020
13F
Arkadios Wealth Advisors
13F
Company
0.03%
20,000
$35,000 31 Dec 2020
13F
Rockefeller Capital Management L.P.
13F
Company
0.03%
20,000
$35,000 31 Dec 2020
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.03%
17,047
$31,000 31 Dec 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
15,000
$27,000 31 Dec 2020
13F
Traynor Capital Management, Inc.
13F
Company
0.02%
14,777
$26,000 31 Dec 2020
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
12,513
$22,000 31 Dec 2020
13F
LPL Financial LLC
13F
Company
0.02%
12,500
$22,000 31 Dec 2020
13F
HRT FINANCIAL LP
13F
Company
0.02%
11,651
$20,000 31 Dec 2020
13F
XTX MARKETS LLC
13F
Company
0.02%
11,019
$20,000 31 Dec 2020
13F
ACT WEALTH MANAGEMENT, LLC
13F
Company
0.01%
10,000
$18,000 31 Dec 2020
13F
CAPTRUST FINANCIAL ADVISORS
13F
Company
0.01%
10,000
$18,000 31 Dec 2020
13F
JPMORGAN CHASE & CO
13F
Company
0%
3,050
$5,000 31 Dec 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
406
$1,000 31 Dec 2020
13F
Sowell Financial Services LLC
13F
Company
0%
300
$1,000 31 Dec 2020
13F
American Portfolios Advisors
13F
Company
0%
228
$408 31 Dec 2020
13F

Institutional Holders of AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) as of Q1 2021

As of 31 Mar 2021, AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,420,355 shares. The largest 10 holders included MORGAN STANLEY, VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Verition Fund Management LLC, CITADEL ADVISORS LLC, and GSA CAPITAL PARTNERS LLP. This page lists 32 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
29
Q1 2021 holders
32
Holder diff
3
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 Value $ Q1 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.